Viewing Study NCT01235793


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2025-12-27 @ 11:02 PM
Study NCT ID: NCT01235793
Status: TERMINATED
Last Update Posted: 2018-11-20
First Post: 2010-11-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma
Sponsor: Cedars-Sinai Medical Center
Organization: